Stay updated on HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page.

Latest updates to the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page
- Check3 days agoChange DetectedThe history shows a new revision (v3.3.3) added and two items removed: HHS Vulnerability Disclosure and Revision: v3.3.2; these are site maintenance/versioning updates rather than trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer shows an updated site revision from v3.2.0 to v3.3.2, which appears to be a minor site version update with no impact on study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding/operating-status notice that warned information on the site may not be up to date. The alert about potential delays and operating status has been deleted from the page.SummaryDifference0.8%

- Check53 days agoChange DetectedNo substantive changes were made in this version; the record shows only the earliest entry with no updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference13%

- Check89 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page.